Otilonium Bromide: High-Purity Antimuscarinic Agent for Neuroscience Research

Executive Summary: Otilonium Bromide (C₂₉H₄₃BrN₂O₄, MW 563.57) is a solid, high-purity (≥98%) antimuscarinic agent supplied by APExBIO for research applications. It functions as a selective acetylcholine receptor (AChR) inhibitor, enabling precise modulation of muscarinic signaling in smooth muscle and neural tissues (see related review). Its solubility profile (≥28.18 mg/mL in DMSO, ≥55.8 mg/mL in water, ≥91 mg/mL in ethanol) facilitates diverse experimental setups. Otilonium Bromide is essential for studying cholinergic pathways and modeling gastrointestinal motility disorders (Smith 2023, DOI). Solutions are stable short-term at -20°C, but long-term use is not recommended due to potential degradation.

Biological Rationale

Muscarinic acetylcholine receptors (mAChRs) regulate smooth muscle tone, neurotransmission, and glandular secretion. Dysregulation of cholinergic signaling is implicated in gastrointestinal motility disorders, overactive bladder, and neurological diseases (Vijayan et al. 2021). Antimuscarinic agents like Otilonium Bromide allow researchers to dissect mAChR-mediated pathways. By selectively inhibiting AChR activity, this compound enables controlled studies of contraction, neurotransmitter release, and receptor pharmacology in both in vitro and ex vivo systems.

Mechanism of Action of Otilonium Bromide

Otilonium Bromide acts as a competitive antagonist at muscarinic acetylcholine receptors (primarily M₂ and M₃ subtypes), blocking the binding of acetylcholine. This results in decreased intracellular calcium mobilization and reduced smooth muscle contraction. The compound has negligible affinity for nicotinic receptors, conferring selectivity for muscarinic pathways (APExBIO product data). In neuroscience applications, this action disrupts cholinergic signaling, providing a model for receptor modulation and synaptic studies.

Evidence & Benchmarks

• Otilonium Bromide inhibits muscarinic receptor-mediated contraction in isolated guinea pig ileum at concentrations ≥10 µM (Vijayan et al. 2021, DOI).
• Solubility benchmarks: ≥28.18 mg/mL in DMSO, ≥55.8 mg/mL in water, and ≥91 mg/mL in ethanol at 25°C (APExBIO).
• High purity (≥98%) confirmed by HPLC and NMR spectroscopy for SKU B1607 (APExBIO).
• Stable at -20°C for up to 12 months in solid form; solutions should be used within 1 week for optimal efficacy (APExBIO).
• Does not interfere with non-cholinergic neurotransmitter pathways at standard research concentrations (see scenario-driven Q&A).

Applications, Limits & Misconceptions

Otilonium Bromide is employed in neuroscience and gastrointestinal research to model smooth muscle spasms, explore cholinergic signaling, and test receptor-targeted therapeutics. It is used in organ bath assays, receptor binding studies, and cell-based models. The high solubility and specificity make it suitable for comparative studies with other antimuscarinic agents (prior review; this article presents updated solubility data and specificity benchmarks).

Common Pitfalls or Misconceptions

• Otilonium Bromide is not a selective inhibitor for nicotinic acetylcholine receptors; it is muscarinic-selective.
• It is strictly for research use only—no diagnostic or therapeutic applications are approved.
• Long-term solution storage (>1 week) at room temperature leads to degradation and reduced activity.
• Not suitable for in vivo use in humans or animals without further validation.
• Does not cross the blood-brain barrier efficiently; CNS effects are limited to ex vivo/in vitro preparations.

Workflow Integration & Parameters

Otilonium Bromide (SKU B1607) is supplied as a solid with high purity (≥98%) by APExBIO. Solutions can be prepared in DMSO, water, or ethanol, with recommended concentrations depending on the assay (e.g., 1–100 µM for organ bath studies). For optimal results, dissolve the compound at room temperature, filter-sterilize if needed, and store aliquots at -20°C. Use freshly prepared solutions within 7 days (product details). For troubleshooting and advanced workflow integration, see this synthesis of benchmark data, which this article extends with updated purity and stability metrics.

Conclusion & Outlook

Otilonium Bromide remains a cornerstone tool for research on cholinergic signaling and smooth muscle pharmacology due to its purity, solubility, and confirmed receptor specificity. Current applications include modeling gastrointestinal motility disorders, optimizing receptor modulation workflows, and benchmarking antimuscarinic pharmacology. As new neurotransmitter targets emerge, Otilonium Bromide provides a reliable reference standard for comparative studies. For full product specifications and ordering, visit the APExBIO Otilonium Bromide page.